Myeloid-Derived Suppressor Cells Correlate With Patient Outcomes in Hepatic Arterial Infusion Chemotherapy for Hepatocellular Carcinoma

Cancer Immunology, Immunotherapy - Germany
doi 10.1007/s00262-016-1837-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Severe Colitis Caused by Hepatic Arterial Infusion Chemotherapy With Cisplatin for Hepatocellular Carcinoma

Internal Medicine
Internal MedicineMedicine
2020English

Hepatic Arterial Infusion Chemotherapy.

Drug Delivery System
Pharmaceutical Science
1997English

Effect of Body Composition on Survival Benefit of Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma: A Comparison With Sorafenib Therapy

PLoS ONE
Multidisciplinary
2019English

Targeting Myeloid-Derived Suppressor Cells in the Treatment of Hepatocellular Carcinoma: Current State and Future Perspectives

Journal of Hepatocellular Carcinoma
2019English

Significance of Trans-Hepatic Arterial Chemotherapy for Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

Oncology Reports
MedicineCancer ResearchOncology
1994English

Hepatic Arterial Infusion of Chemotherapy for Hepatic Metastases From Colorectal Cancer

Cancer Control
MedicineOncologyHematology
2006English

A Prognostic Evaluation of Hepatic Arterial Injection Chemotherapy With Cisplatin Suspended in Lipiodol for Hepatocellular Carcinoma.

Drug Delivery System
Pharmaceutical Science
1990English

Myeloid-Derived Suppressor Cells Show Different Frequencies in Diabetics and Subjects With Arterial Hypertension

Journal of Diabetes Research
EndocrinologyMetabolismDiabetes
2019English

Regulation of Accumulation and Function of Myeloid Derived Suppressor Cells in Different Murine Models of Hepatocellular Carcinoma

Journal of Hepatology
Hepatology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy